AveXis Announces Appointments of Daniel G. Welch, Terrence C. Kearney and Frank Verwiel, M.D. to Board of Directors
March 07, 2016 08:00 ET
|
AveXis, Inc.
CHICAGO, March 07, 2016 (GLOBE NEWSWIRE) -- AveXis, Inc. (Nasdaq:AVXS), a leading clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening...
AveXis Announces Pricing of Initial Public Offering
February 10, 2016 21:33 ET
|
AveXis, Inc.
CHICAGO, Feb. 10, 2016 (GLOBE NEWSWIRE) -- AveXis, Inc. (Nasdaq:AVXS), a clinical stage gene therapy company developing treatments for patients suffering from rare and life-threatening...